SB 1428 creates the Office of Alzheimer’s Disease and Related Dementia Service Coordination within Oklahoma’s State Department of Health, effective November 1, 2026. The office will coordinate statewide dementia services, eliminate duplicated efforts, collect data, support staff training, and identify grant opportunities to improve care for individuals with Alzheimer’s or related dementias and their caregivers. It requires the office to maintain a full-time dementia services coordinator position to manage operations. The bill repeals two outdated sections of Oklahoma law (63 O.S. 2021, Sections 1-879.2 and 1-879.3) related to dementia services.
HB 1168 makes it a felony to knowingly deliver or possess abortion-inducing drugs (like misoprostol or methotrexate) with the intent of causing an abortion, punishable by up to $100,000 in fines or 10 years in prison. It directly affects individuals who provide such drugs for non-exceptional purposes, including off-label use for abortion. Key exceptions include pharmacists, manufacturers, and distributors acting within lawful medical practices, as well as preventive contraception used as directed by manufacturers. The law does not restrict treatment for ectopic pregnancies, miscarriages, or medical uses of drugs like chemotherapy.
HB 3143 extends Oklahoma's moratorium on new medical marijuana business licenses (dispensaries, processors, growers) from August 1, 2026, to August 1, 2028. It requires existing license holders to get written approval from the Oklahoma Medical Marijuana Authority before transferring ownership, including submitting documentation to the Oklahoma State Bureau of Narcotics. Transfers must follow a 15-business-day timeline for license and registration changes, and applicants cannot submit transfer requests if disciplinary actions are pending. The bill also mandates that businesses provide a full inventory of all medical marijuana products during ownership changes and prohibits transfers without approval, with a 30-day window for pending applications to comply with new rules.
SB 1344 creates Oklahoma's Insulin Access and Affordability Program, administered by the State Department of Health, to increase access to affordable insulin for residents. The bill requires the Department to provide financial support to a nonprofit pharmaceutical manufacturer developing fast-acting biosimilar insulin, contingent on the manufacturer matching funds and agreeing to produce insulin at low cost without rebates (except as required by law). The agreement includes annual reporting on development progress and repayment terms if the insulin isn't produced and distributed as promised. This program directly affects Oklahoma residents needing insulin, public and private payors, and the specified nonprofit manufacturer.
SB 1134 allocates $100,000 from Oklahoma's General Revenue Fund to the Oklahoma Health Care Authority for the 2026 fiscal year. The bill directly provides funding for the Authority to carry out its legal duties. It declares an emergency to allow immediate implementation upon passage. This is a procedural appropriations measure with no policy changes beyond the specified funding amount.
SB 1142 allocates $100,000 from unallocated state funds to Oklahoma's Department of Mental Health and Substance Abuse Services for the 2025-2026 fiscal year. The funding is intended to support the department's existing duties, including providing mental health and substance abuse services to Oklahomans. The bill declares an emergency to allow immediate implementation upon approval, bypassing standard legislative timelines. This is a procedural funding measure, not a policy change, and remains pending before the Appropriations Committee.
This bill proposes a constitutional amendment to establish the "Tobacco Settlement Endowment Trust Fund" for Oklahoma's tobacco settlement funds. It requires that at least 75% of new tobacco settlement payments (after 2001) be deposited into this trust fund, with specific percentages increasing over time. The trust fund's earnings must be used for cancer research, tobacco prevention programs, children's health initiatives, senior care programs, and education-related expenses, with unused funds remaining in the trust. The amendment creates two governing boards to manage investments and allocate funds, and it would require voter approval before taking effect.
HB 2947 adds a new provider code in Oklahoma Medicaid for master's and doctoral-level behavioral health clinical interns. These interns - graduate students in nationally accredited programs - can provide services under the direct supervision of licensed behavioral health providers (like LPCs or LCSWs) while following all Medicaid documentation and training requirements. The bill directly affects interns seeking practical experience and licensed supervisors who will oversee their Medicaid-covered services. It expands Medicaid access to behavioral health care by formalizing intern participation in the state's Medicaid plan.
HB 3901 establishes a pilot program for psychological autopsies in Oklahoma, which investigate ambiguous deaths (like suicides) to reconstruct a deceased person's mental state and influences. The Commissioner of Health must appoint a full-time psychological autopsy examiner who will submit annual progress reports and coordinate with mental health and medical examiner offices. The pilot runs until November 1, 2031, with a recommendation for permanency or termination. Its goal is to use data from these reviews to inform suicide prevention efforts, without changing existing laws or creating new obligations for individuals.
HB 3904 requires Oklahoma Medicaid to reimburse specific maternal health services for pregnant and postpartum women. It changes payment rules to separately cover prenatal, delivery, and postpartum care (instead of bundled payments), implements immediate presumptive eligibility for prenatal care, and adds reimbursement for depression screening, self-measured blood pressure monitoring, remote ultrasounds, and doula/community health worker services. The bill directs the Oklahoma Health Care Authority to adopt implementing rules and seek federal approvals, effective November 1, 2026. It directly affects Medicaid-covered pregnant and postpartum individuals in Oklahoma by expanding access to targeted health services.
